Patent · US Active

Therapeutic agent for accelerating recovery of animal under medical treatment

US9078868B2 · kind B2 · utility

0Cited by
1References
25Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 14, 2011
Grant dateJul 14, 2015
Priority date
Expiry dateJun 5, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/2264
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An object of the present invention is to provide a therapeutic agent for accelerating recovery to accelerate a return to normal physical conditions by administering to an animal not in good health and under medical treatment, a treatment method, and the like. There is provided a therapeutic agent for accelerating recovery for animal use to accelerate the improvement of a physical condition of an animal under medical treatment which has a decreased activity (vigor) and is exhausted, which contains ghrelin or a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient and improves one or more of evaluation parameters consisting of activity (vigor), blood cell test values, biochemical test values, body temperature, the degree of anger or anxiety, and respiratory rate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.